Stress-induced amenorrhea – possibilities for non-hormonal correction

Authors

DOI:

https://doi.org/10.18370/2309-4117.2024.74.13-24

Keywords:

amenorrhea, functional hypothalamic amenorrhea, stress, anxiety, phytotherapy, Vitex agnus castus

Abstract

Background. Menstrual cycle disorders associated with stress, particularly functional hypothalamic amenorrhea, are a common condition among women of reproductive age in the context of martial law. Stress-induced amenorrhea not only causes reduced fertility and quality of life for women but also poses a future risk due to related general health disorders among the female population of Ukraine. There are reports in the literature about the effectiveness of etiological treatment for these disorders in the form of psychological counseling with additional supplementation, which prompted us to explore the possibilities of non-hormonal correction of stress-induced amenorrhea. Objective of the study: to optimize the treatment of stress-induced amenorrhea by non-hormonal medication therapy combined with phytotherapy alongside psychological counseling.
Materials and methods. A total of 106 women of reproductive age with stress-induced amenorrhea were examined, receiving psychological counseling and medication therapy. The patients were randomized into three groups: 34 patients received Vitex agnus castus extract BNO 1095, 35 women were prescribed a preparation containing magnesium citrate and vitamin B6, and 37 participants received a combination of both treatments for six months.
Results. After six months menstrual cycles were restored in 22 (64.71%) women who received Vitex agnus castus, in 19 (55.88%) patients who received magnesium citrate, and in 29 (78.4%) patients who received combined treatment. This was accompanied by the normalization of gonadotropic function of the pituitary gland, steroidogenic function of the ovaries, and endometrial thickness.
Conclusions. Stabilization of the mental state and reduction of anxiety levels are key etiological interventions and essential conditions for restoring menstrual cycle regularity in patients with stress-induced amenorrhea. The mild dopaminergic support in the form of standardized Vitex agnus castus extract BNO 1095 (Cyclodynon) helps to restore hormonal balance and the menstrual cycle in women with stress-induced amenorrhea, especially when combined with magnesium supplements and psychological counseling. The obtained data allow to recommend this treatment regimen as first-line therapy for women with stress-induced amenorrhea to preserve and restore reproductive function that is especially relevant in the conditions of the military conflict in Ukraine.

Author Biographies

T.F. Tatarchuk, SI «All-Ukrainian Center of Maternity and Childhood of the NAMS of Ukraine»; SSI «Center of Innovative Medical Technologies of the NAS of Ukraine», Kyiv

MD, professor, corresponding member of the National Academy of Medical Sciences of Ukraine, deputy director for scientific work, head of the Department of Endocrine Gynecology;
chief researcher, Reproductive Health Department

N.V. Kosei, SI «All-Ukrainian Center of Motherhood and Childhood of the NAMS of Ukraine»; SSI «Center of Innovative Medical Technologies of the NAS of Ukraine», Kyiv

MD, professor, chief researcher, Department of Endocrine Gynecology;
head of the Reproductive Health Department

V.M. Yakimets, SSI “Center of Innovative Medical Technologies of the NAS of Ukraine», Kyiv

MD, deputy director for scientific, organizational and methodological work

K.D. Plaksiieva, SSI “Center of Innovative Medical Technologies of the NAS of Ukraine», Kyiv

PhD, senior researcher, Department of Reproductive Health

S.I. Regeda, SI «All-Ukrainian Center of Motherhood and Childhood of the NAMS of Ukraine»; SSI «Center of Innovative Medical Technologies of the NAS of Ukraine», Kyiv

PhD, senior researcher, Department of Endocrine Gynecology;
head of the Gynecology Department

A.Y. Pylypenko, SI «All-Ukrainian Center of Motherhood and Childhood of the NAMS of Ukraine», Kyiv

Graduate student, Endocrine Gynecology Department

References

  1. Gardani M, Bradford DRR, Russell K, et al. A systematic review and meta-analysis of poor sleep, insomnia symptoms and stress in undergraduate students. Sleep Med Rev. 2022 Feb;61:101565. DOI: 10.1016/j.smrv.2021.101565
  2. Kruk J, Aboul-Enein BH, Bernstein J, Gronostaj M. Psychological Stress and Cellular Aging in Cancer: A Meta-Analysis. Oxid Med Cell Longev. 2019 Nov 13;2019:1270397. DOI: 10.1155/2019/1270397
  3. Meier JK, Weymar M, Schwabe L. Stress Alters the Neural Context for Building New Memories. J Cogn Neurosci. 2020 Dec; 32(12):2226–40. DOI: 10.1162/jocn_a_01613
  4. McEwen BS, Akil H. Revisiting the Stress Concept: Implications for Affective Disorders. J Neurosci. 2020 Jan 2;40(1):12–21. DOI: 10.1523/JNEUROSCI.0733-19.2019
  5. Sophie Gibson ME, Fleming N, Zuijdwijk C, Dumont T. Where Have the Periods Gone? The Evaluation and Management of Functional Hypothalamic Amenorrhea. J Clin Res Pediatr Endocrinol. 2020 Feb 6;12(Suppl 1):18–27. DOI: 10.4274/jcrpe.galenos.2019.2019.S0178
  6. Saadedine M, Kapoor E, Shufelt C. Functional Hypothalamic Amenorrhea: Recognition and Management of a Challenging Diagnosis. Mayo Clin Proc. 2023 Sep;98(9):1376–85. DOI: 10.1016/j.mayocp.2023.05.027
  7. Bonazza F, Politi G, Leone D, et al. Psychological factors in functional hypothalamic amenorrhea: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023 Jan 27;14:981491. DOI: 10.3389/fendo.2023.981491
  8. Indirli R, Lanzi V, Mantovani G, et al. Bone health in functional hypothalamic amenorrhea: What the endocrinologist needs to know. Front Endocrinol (Lausanne). 2022 Oct 11;13:946695. DOI: 10.3389/fendo.2022.946695
  9. Ryterska K, Kordek A, Załęska P. Has Menstruation Disappeared? Functional Hypothalamic Amenorrhea-What Is This Story about? Nutrients. 2021 Aug 17;13(8):2827. DOI: 10.3390/nu13082827
  10. Dietz BM, Hajirahimkhan A, Dunlap TL, Bolton JL. Botanicals and Their Bioactive Phytochemicals for Women’s Health. Pharmacol Rev. 2016 Oct;68(4):1026–73. DOI: 10.1124/pr.115.010843
  11. Echeverria V, Echeverria F, Barreto GE, et al. Estrogenic Plants: to Prevent Neurodegeneration and Memory Loss and Other Symptoms in Women After Menopause. Front Pharmacol. 2021 May 20:12:644103. DOI: 10.3389/fphar.2021.644103
  12. Hoepner CT, McIntyre RS, Papakostas GI. Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence. Nutrients. 2021 Feb 26;13(3):767. DOI: 10.3390/nu13030767
  13. McCabe D, Lisy K, Lockwood C, Colbeck M. The impact of essential fatty acid, B vitamins, vitamin C, magnesium and zinc supplementation on stress levels in women: a systematic review. JBI Database System Rev Implement Rep. 2017 Feb;15(2):402–53. DOI: 10.11124/JBISRIR-2016-002965
  14. Konrad M, Schlingmann KP, Gudermann T. Insights into the molecular nature of magnesium homeostasis. Am J Physiol Renal Physiol. 2004 Apr;286(4):F599–605. DOI: 10.1152/ajprenal.00312.2003
  15. Moabedi M, Aliakbari M, Erfanian S, Milajerdi A. Magnesium supplementation beneficially affects depression in adults with depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Front Psychiatry. 2023 Dec 22;14:1333261. DOI: 10.3389/fpsyt.2023.1333261
  16. Pham PC, Pham PM, Pham SV, et al. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2007 Mar;2(2):366-73. DOI: 10.2215/CJN.02960906
  17. DiNicolantonio JJ, O’Keefe JH, Wilson W. Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart. 2018 Jan 13;5(1):e000668. DOI: 10.1136/openhrt-2017-000668.
  18. Macian N, Dualé C, Voute M, et al. Short-Term Magnesium Therapy Alleviates Moderate Stress in Patients with Fibromyalgia: A Randomized Double-Blind Clinical Trial. Nutrients. 2022 May 17;14(10):2088. DOI: 10.3390/nu14102088
  19. Botturi A, Ciappolino V, Delvecchio G, et al. The Role and the Effect of Magnesium in Mental Disorders: A Systematic Review. Nutrients. 2020 Jun 3;12(6):1661. DOI: 10.3390/nu12061661
  20. Pickering G, Mazur A, Trousselard M, et al. Magnesium Status and Stress: The Vicious Circle Concept Revisited. Nutrients. 2020 Nov 28;12(12):3672. DOI: 10.3390/nu12123672
  21. Pouteau E, Kabir-Ahmadi M, Noah L, et al. Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: A randomized, single-blind clinical trial. PLoS One. 2018 Dec 18;13(12):e0208454. DOI: 10.1371/journal.pone.0208454
  22. Afsharfar M, Shahraki M, Shakiba M, et al. The effects of magnesium supplementation on serum level of brain derived neurotrophic factor (BDNF) and depression status in patients with depression. Clin Nutr ESPEN. 2021 Apr;42:381–6. DOI: 10.1016/j.clnesp.2020.12.022
  23. Noah L, Dye L, Bois De Fer B, et al. Effect of magnesium and vitamin B6 supplementation on mental health and quality of life in stressed healthy adults: Post-hoc analysis of a randomised controlled trial. Stress Health. 2021 Dec;37(5):1000–9. DOI: 10.1002/smi.3051. Epub 2021 May 6
  24. Askari M, Mozaffari H, Jafari A, et al. The effects of magnesium supplementation on obesity measures in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2021;61(17):2921–37. DOI: 10.1080/10408398.2020.1790498
  25. Chan V, Lo K. Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis. Postgrad Med J. 2022 Apr;98(1158):285–93. DOI: 10.1136/postgradmedj-2020-139319
  26. Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. BMC Complement Med Ther. 2021 Apr 17;21(1):125. DOI: 10.1186/s12906-021-03297-z
  27. Farsinejad-Marj M, Azadbakht L, Mardanian F, et al. Clinical and Metabolic Responses to Magnesium Supplementation in Women with Polycystic Ovary Syndrome. Biol Trace Elem Res. 2020 Aug;196(2):349–58. DOI: 10.1007/s12011-019-01923-z
  28. Veronese N, Demurtas J, Pesolillo G, et al. Magnesium and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational and intervention studies. Eur J Nutr. 2020 Feb;59(1):263–72. DOI: 10.1007/s00394-019-01905-w.
  29. Ban Y, Xia T, Jing R, et al. Vitex Diterpenoids: Structural Diversity and Pharmacological Activity. Curr Pharm Des. 2020;26(1):138–59. DOI: 10.2174/1381612825666191216151703
  30. Puglia LT, Lowry J, Tamagno G. Vitex agnus castus effects on hyperprolactinaemia. Front Endocrinol (Lausanne). 2023 Nov 21;14:1269781. DOI: 10.3389/fendo.2023.1269781
  31. Naber KG, Apolikhin O, Kozlov V, Kennedy DW. Review of the Phytoneering Research & Experience Summit (PRES) 2019 “building bridges between nature’s healing potential and evidence-based medicine – 20 years of phytoneering”. Clin Phytoscience2020 Feb 17 ;6(1). DOI: 10.1186/s40816-020-0155-6
  32. Ooi SL, Watts S, McClean R, Pak SC. Vitex Agnus-castus for the treatment of cyclic mastalgia: a systematic review and meta-analysis. Reprod Health Woman. 2021 May 3;3:21–33. DOI: 10.30841/2708-8731.3.2021.234230
  33. Jang SH, Kim DI, Choi MS. Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review. BMC Complement Altern Med. 2014 Jan 10;14(1):11. DOI: 10.1186/1472-6882-14-11
  34. Sepede G, Brunetti M, Di Giannantonio M. Comorbid Premenstrual Dysphoric Disorder in Women with Bipolar Disorder: Management Challenges. Neuropsychiatr Dis Treat. 2020 Feb 16:415–26. DOI: 10.2147/ndt.s202881
  35. Sundström-Poromaa I, Comasco E. New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder. CNS Drugs 2023 May 12;37(5):371–9. DOI: 10.1007/s40263-023-01004-9
  36. De Franciscis P, Grauso F, Luisi A, et al. Adding Agnus Castus and Magnolia to Soy Isoflavones Relieves Sleep Disturbances Besides Postmenopausal Vasomotor Symptoms-Long Term Safety and Effectiveness. Nutrients. 2017 Feb 13;9(2):129. DOI: 10.3390/nu9020129
  37. Zeidabadi A, Emamghoreishi M, Tayebi N, Akbarzadeh M. Effect of Vitex Agnus-Castus extract on hot flushes, night sweats, sleep disorders and some other symptoms in postmenopausal women: a clinical trial study. Aust J Herb Naturop Med. 2022 Dec;34(4). DOI: 10.33235/ajhnm.34.4.148-154
  38. Farzaei M, Niroumand M, Heydarpour F. Pharmacological and therapeutic effects of Vitex agnus-castus L.: A review. Pharmacogn Rev. 2018;12(23):103. DOI: 10.4103/phrev.phrev_22_17
  39. Duquenne P, Samieri C, Chambaron S, et al. Chronic insomnia, high trait anxiety and their comorbidity as risk factors for incident type 2 diabetes mellitus. Sci Rep. 2024 May 24;14(1):11927. DOI: 10.1038/s41598-024-62675-y
  40. Zsido AN, Teleki SA, Csokasi K, et al. Development of the short version of the spielberger state-trait anxiety inventory. Psychiatry Res. 2020 Sep;291:113223. DOI: 10.1016/j.psychres.2020.113223.
  41. Alqurashi YD, Dawidziuk A, Alqarni A, et al. A visual analog scale for the assessment of mild sleepiness in patients with obstructive sleep apnea and healthy participants. Ann Thorac Med. 2021 Apr-Jun;16(2):141–7. DOI: 10.4103/atm.ATM_437_20
  42. Fabbri M, Beracci A, Martoni M, et al. Measuring Subjective Sleep Quality: A Review. Int J Environ Res Public Health. 2021 Jan 26;18(3):1082. DOI: 10.3390/ijerph18031082

Downloads

Published

2024-11-29

How to Cite

Tatarchuk, T., Kosei, N., Yakimets, V., Plaksiieva, K., Regeda, S., & Pylypenko, A. (2024). Stress-induced amenorrhea – possibilities for non-hormonal correction. REPRODUCTIVE ENDOCRINOLOGY, (74), 13–24. https://doi.org/10.18370/2309-4117.2024.74.13-24

Issue

No. 74 (2024)

Section

Gynecology

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.